Panel Discussion

Monday, March 9, 2026

10:30 AM - 10:50 AM EST

Location: Spotlight Theater

Moderator(s)

Lawrence Biegelsen, MBA

Managing Director Medical Supplies & Devices
Wells Fargo
Short Hills, New Jersey, United States

Disclosure(s): No financial relationships to disclose
Rick Wise, CFA

Research Analyst
Stifel
New York, New York, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Michael J. Bloch, MD

Medical Director, Vascular Care
Renown Institute for Heart and Vascular Health
reno, Nevada, United States

Disclosure(s): Amgen Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Coravie: Consulting Fees (e.g., advisory boards) (Ongoing); corcept: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); esperion: Consulting Fees (e.g., advisory boards) (Ongoing); idorsia: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); mineralyx: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); novartis: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Jason Fontana, PhD

VP/GM Renal Denervation
Medtronic
San Diego, California, United States

Disclosure(s): Medtronic: Employee (Ongoing)
Vijay Iyer, MD, PhD

Associate Professor
University at Buffalo
East Amherst, New York, United States

Disclosure(s): Edwards Lifesciences LLC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing); Otsuka Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing)
AN

Aravinda Nanjundappa, MD, FSCAI

Director of Peripheral Vascular Interventions, Cardiovascular Division
Cleveland Clinic , Main Campus
Pepper pike, Ohio, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Lawrence Biegelsen, MBA: No financial relationships to disclose

Rick Wise, CFA: No financial relationships to disclose

Michael J. Bloch, MD: Amgen Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Coravie: Consulting Fees (e.g., advisory boards) (Ongoing); corcept: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); esperion: Consulting Fees (e.g., advisory boards) (Ongoing); idorsia: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); mineralyx: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); novartis: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Jason Fontana, PhD: Medtronic: Employee (Ongoing)

Vijay Iyer, MD, PhD: Edwards Lifesciences LLC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing); Otsuka Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing)

Aravinda Nanjundappa, MD, FSCAI: No financial relationships to disclose